Cargando…

Nitrogen-Containing Bisphosphonates Downregulate Cathepsin K and Upregulate Annexin V in Osteoclasts Cultured In Vitro

INTRODUCTION: Bisphosphonates are widely used in the treatment of osteoporosis; however, they are associated with the serious adverse event of bisphosphonate‐related osteonecrosis of the jaw (BRONJ). AIM: The aim of this study is to assess the effects of nitrogen-containing bisphosphonates (N-PHs) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bautista-Carbajal, Arturo, Villanueva-Arriaga, Rosina Eugenia, Páez-Arenas, Araceli, Massó-Rojas, Felipe, Frechero Molina, Nelly, García-López, Salvador
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974278/ https://www.ncbi.nlm.nih.gov/pubmed/36866025 http://dx.doi.org/10.1155/2023/2960941

Ejemplares similares

Giant osteoclasts in patients under bisphosphonates
por: Mac-Way, Fabrice, et al.
Publicado: (2014)

Fluoruros en agua de consumo al norte y occidente de México
por: Vázquez-Bojórquez, Claudia, et al.
Publicado: (2022)

Is the Use of Bisphosphonates Putting Horses at Risk? An Osteoclast Perspective
por: Vergara-Hernandez, Fernando B., et al.
Publicado: (2022)

RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro
por: Sutherland, Karen A, et al.
Publicado: (2009)

Influence of Bisphosphonate Treatment on Medullary Macrophages and Osteoclasts: An Experimental Study
por: Escudero, Natalia Daniela, et al.
Publicado: (2012)

IFN-β mediates the anti-osteoclastic effect of bisphosphonates and dexamethasone
por: Kalkar, Prajakta, et al.
Publicado: (2022)

Geranylgeraniol Application in Human Osteoblasts and Osteoclasts for Reversal of the Effect of Bisphosphonates
por: Jung, Junho, et al.
Publicado: (2023)

Live imaging of osteoclast inhibition by bisphosphonates in a medaka osteoporosis model
por: Yu, Tingsheng, et al.
Publicado: (2016)

Inhibition of Osteoclast Differentiation and Bone Resorption by Bisphosphonate-conjugated Gold Nanoparticles
por: Lee, Donghyun, et al.
Publicado: (2016)

The intrasulcular application effect of bisphosphonate hydrogel toward osteoclast activity and relapse movement
por: Utari, Tita Ratya, et al.
Publicado: (2021)

Osteopenia Due to Enhanced Cathepsin K Release by BK Channel Ablation in Osteoclasts
por: Sausbier, Ulrike, et al.
Publicado: (2011)

Effects of the cathepsin K inhibitor with mineral trioxide aggregate cements on osteoclastic activity
por: Kim, Hee-Sun, et al.
Publicado: (2019)

Myocardial cathepsin D is downregulated in sudden cardiac death
por: Kakimoto, Yu, et al.
Publicado: (2020)

Sclerostin expression in trabecular bone is downregulated by osteoclasts
por: Koide, Masanori, et al.
Publicado: (2020)

Inhibition of Triple-Negative Breast Cancer Cell Aggressiveness by Cathepsin D Blockage: Role of Annexin A1
por: Zóia, Mariana Alves Pereira, et al.
Publicado: (2019)

Therapeutic targeting of osteoclasts by osteoprotegerin and bisphosphonates leads to a reduction of TNFalpha-mediated bone resorption
por: Redlich, K, et al.
Publicado: (2001)

Novel cathepsin K inhibitors block osteoclasts in vitro and increase spinal bone density in zebrafish
por: Xue, Si-tu, et al.
Publicado: (2019)

Cathepsin K(+) Non-Osteoclast Cells in the Skeletal System: Function, Models, Identity, and Therapeutic Implications
por: Zou, Nanyu, et al.
Publicado: (2022)

Adipose tissue dysfunction serum markers are associated with high density lipoprotein size and glycation in the early stages of type 2 diabetes
por: Jorge-Galarza, Esteban, et al.
Publicado: (2023)

Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis
por: Zhu, Guochun, et al.
Publicado: (2022)

Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
por: Gross, Christian, et al.
Publicado: (2017)

Bisphosphonate-based hydrogel mediates biomimetic negative feedback regulation of osteoclastic activity to promote bone regeneration
por: Li, Zhuo, et al.
Publicado: (2021)

A protocol for visualizing active cathepsin K in osteoclasts with a quenched-fluorescence-activity-based probe
por: Korba, Aleksandra, et al.
Publicado: (2023)

Ar-turmerone inhibits the proliferation and mobility of glioma by downregulating cathepsin B
por: Cao, Wenpeng, et al.
Publicado: (2023)

Searching for perturbed biological pathways and genes through analyzing the expression profile changes in osteoclasts after treatment by bisphosphonates
por: Zhao, Long, et al.
Publicado: (2019)

Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption
por: Ren, Zhong-Yuan, et al.
Publicado: (2015)

The annexins
por: Moss, Stephen E, et al.
Publicado: (2004)

Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates
por: Nagashima, Masakazu, et al.
Publicado: (2012)

Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model
por: Zhu, Sheng, et al.
Publicado: (2020)

Bisphosphonate‐enoxacin inhibit osteoclast formation and function by abrogating RANKL‐induced JNK signalling pathways during osteoporosis treatment
por: Xu, Qiang, et al.
Publicado: (2021)

An SNX10-dependent mechanism downregulates fusion between mature osteoclasts
por: Barnea-Zohar, Maayan, et al.
Publicado: (2021)

Actin-binding protein coronin 1A controls osteoclastic bone resorption by regulating lysosomal secretion of cathepsin K
por: Ohmae, Saori, et al.
Publicado: (2017)

Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer
por: Du, Ruikai, et al.
Publicado: (2018)

Annexins in Glaucoma
por: Yap, Timothy E., et al.
Publicado: (2018)

CathepsinKCre mediated deletion of βcatenin results in dramatic loss of bone mass by targeting both osteoclasts and osteoblastic cells
por: Ruiz, Paula, et al.
Publicado: (2016)

oxLDL inhibits differentiation and functional activity of osteoclasts via scavenger receptor-A mediated autophagy and cathepsin K secretion
por: Dawodu, Damilola, et al.
Publicado: (2018)

Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways
por: Ihn, Hye Jung, et al.
Publicado: (2017)

Effect on Osteoclast Differentiation and ER Stress Downregulation by Amygdalin and RANKL Binding Interaction
por: Trang, Nguyen Minh, et al.
Publicado: (2022)

DCIR suppresses osteoclastic proliferation and resorption by downregulating M-CSF and RANKL signaling
por: Kaifu, Tomonori, et al.
Publicado: (2023)

Improved Efficiency of Cardiomyocyte-Like Cell Differentiation from Rat Adipose Tissue-Derived Mesenchymal Stem Cells with a Directed Differentiation Protocol
por: Ibarra-Ibarra, Blanca Rebeca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oucbtesn823gc8tkcccoqcimpt